OPKO Health, Inc. Amortization of Intangible Assets
OPKO Health, Inc. (OPK) reported Amortization of Intangible Assets of $18.97 million for the 3-month period ending 2026-06-30, per its 10-Q/A filed 2026-08-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-28
- OPKO Health, Inc. amortization of intangible assets for the quarter ending 2026-06-30 was $18.97M, a 2.44% decline year-over-year.
- OPKO Health, Inc. amortization of intangible assets for the quarter ending 2026-03-31 was $18.97M, a 4.51% decline year-over-year.
- OPKO Health, Inc. amortization of intangible assets for the quarter ending 2025-12-31 was $19.05M, a 6.34% decline year-over-year.
- OPKO Health, Inc. amortization of intangible assets for the quarter ending 2025-09-30 was $19.53M, a 4.41% decline year-over-year.
- OPKO Health, Inc. amortization of intangible assets for fiscal 2025 was $77.89M, a 5.74% decline from fiscal 2024.
- OPKO Health, Inc. amortization of intangible assets for fiscal 2024 was $82.63M, a 3.95% decline from fiscal 2023.
- OPKO Health, Inc. amortization of intangible assets for fiscal 2023 was $86.03M, a 2.00% decline from fiscal 2022.
- OPKO Health, Inc. amortization of intangible assets for fiscal 2022 was $87.78M, a 74.60% increase from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $18.97M 10-Q/A · filed 2026-08-28 | $37.94M 10-Q/A · filed 2026-08-28 | $56.99M derived: sum of 3 quarters · filed 2026-08-28 | $76.52M derived: sum of 4 quarters · filed 2026-08-28 | |
| 2026-03-31 | $18.97M 10-Q/A · filed 2026-08-28 | $38.02M derived: sum of 2 quarters · filed 2026-08-28 | $57.55M derived: sum of 3 quarters · filed 2026-08-28 | $77.00M derived: sum of 4 quarters · filed 2026-08-28 | |
| 2025-12-31 | $19.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $38.59M derived: sum of 2 quarters · filed 2026-02-26 | $58.03M derived: sum of 3 quarters · filed 2026-08-28 | $77.89M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $19.53M 10-Q · filed 2025-10-29 | $38.98M derived: sum of 2 quarters · filed 2026-08-28 | $58.84M 10-Q · filed 2025-10-29 | $79.18M derived: sum of 4 quarters · filed 2026-08-28 | |
| 2025-06-30 | $19.44M 10-Q/A · filed 2026-08-28 | $39.30M 10-Q/A · filed 2026-08-28 | $59.65M derived: sum of 3 quarters · filed 2026-08-28 | $80.08M derived: sum of 4 quarters · filed 2026-08-28 | |
| 2025-03-31 | $19.86M 10-Q/A · filed 2026-08-28 | $40.20M derived: sum of 2 quarters · filed 2026-08-28 | $60.64M derived: sum of 3 quarters · filed 2026-08-28 | $81.06M derived: sum of 4 quarters · filed 2026-08-28 | |
| 2024-12-31 | $20.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $40.78M derived: sum of 2 quarters · filed 2026-02-26 | $61.20M derived: sum of 3 quarters · filed 2026-02-26 | $82.63M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $20.43M 10-Q · filed 2025-10-29 | $40.85M derived: sum of 2 quarters · filed 2025-10-29 | $62.29M 10-Q · filed 2025-10-29 | $83.78M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | $20.42M 10-Q · filed 2025-07-31 | $41.86M 10-Q · filed 2025-07-31 | $63.35M derived: sum of 3 quarters · filed 2026-02-26 | $84.88M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $21.44M 10-Q · filed 2025-05-01 | $42.93M derived: sum of 2 quarters · filed 2026-02-26 | $64.46M derived: sum of 3 quarters · filed 2026-02-26 | $86.00M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | $21.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $43.02M derived: sum of 2 quarters · filed 2026-02-26 | $64.56M derived: sum of 3 quarters · filed 2026-02-26 | $86.03M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $21.53M 10-Q · filed 2024-11-07 | $43.07M derived: sum of 2 quarters · filed 2024-11-07 | $64.54M 10-Q · filed 2024-11-07 | $86.10M derived: sum of 4 quarters · filed 2025-03-03 | |
| 2023-06-30 | $21.54M 10-Q · filed 2024-08-07 | $43.01M 10-Q · filed 2024-08-07 | $64.57M derived: sum of 3 quarters · filed 2025-03-03 | $85.97M derived: sum of 4 quarters · filed 2025-03-03 | |
| 2023-03-31 | $21.47M 10-Q · filed 2024-05-07 | $43.03M derived: sum of 2 quarters · filed 2025-03-03 | $64.44M derived: sum of 3 quarters · filed 2025-03-03 | $87.23M derived: sum of 4 quarters · filed 2025-03-03 | |
| 2022-12-31 | $21.56M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $42.97M derived: sum of 2 quarters · filed 2025-03-03 | $65.76M derived: sum of 3 quarters · filed 2025-03-03 | $87.78M 10-K · filed 2025-03-03 | |
| 2022-09-30 | $21.41M 10-Q · filed 2023-11-06 | $44.20M derived: sum of 2 quarters · filed 2023-11-06 | $66.22M 10-Q · filed 2023-11-06 | $78.74M derived: sum of 4 quarters · filed 2024-03-01 | |
| 2022-06-30 | $22.79M 10-Q · filed 2023-08-03 | $44.82M 10-Q · filed 2023-08-03 | $57.34M derived: sum of 3 quarters · filed 2024-03-01 | $69.94M derived: sum of 4 quarters · filed 2024-03-01 | |
| 2022-03-31 | $22.02M 10-Q · filed 2023-05-03 | $34.54M derived: sum of 2 quarters · filed 2024-03-01 | $47.15M derived: sum of 3 quarters · filed 2024-03-01 | $59.73M derived: sum of 4 quarters · filed 2024-03-01 | |
| 2021-12-31 | $12.52M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $25.13M derived: sum of 2 quarters · filed 2024-03-01 | $37.70M derived: sum of 3 quarters · filed 2024-03-01 | $50.28M 10-K · filed 2024-03-01 | |
| 2021-09-30 | $12.61M 10-Q · filed 2022-11-08 | $25.18M derived: sum of 2 quarters · filed 2022-11-08 | $37.76M 10-Q · filed 2022-11-08 | $50.40M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2021-06-30 | $12.57M 10-Q · filed 2022-08-04 | $25.15M 10-Q · filed 2022-08-04 | $37.79M derived: sum of 3 quarters · filed 2023-02-27 | $51.67M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2021-03-31 | $12.58M 10-Q · filed 2022-05-09 | $25.21M derived: sum of 2 quarters · filed 2023-02-27 | $39.09M derived: sum of 3 quarters · filed 2023-02-27 | $54.03M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2020-12-31 | $12.64M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $26.52M derived: sum of 2 quarters · filed 2023-02-27 | $41.45M derived: sum of 3 quarters · filed 2023-02-27 | $56.39M 10-K · filed 2023-02-27 | |
| 2020-09-30 | $13.88M 10-Q · filed 2021-10-28 | $28.82M derived: sum of 2 quarters · filed 2021-10-28 | $43.75M 10-Q · filed 2021-10-28 | $59.14M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-06-30 | $14.94M 10-Q · filed 2021-07-29 | $29.87M 10-Q · filed 2021-07-29 | $45.27M derived: sum of 3 quarters · filed 2022-03-01 | $61.68M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-03-31 | $14.94M 10-Q · filed 2021-04-28 | $30.33M derived: sum of 2 quarters · filed 2022-03-01 | $46.74M derived: sum of 3 quarters · filed 2022-03-01 | $63.16M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2019-12-31 | $15.39M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $31.80M derived: sum of 2 quarters · filed 2022-03-01 | $48.22M derived: sum of 3 quarters · filed 2022-03-01 | $64.78M 10-K · filed 2022-03-01 | |
| 2019-09-30 | $16.41M 10-Q · filed 2020-10-29 | $32.83M derived: sum of 2 quarters · filed 2020-10-29 | $49.39M 10-Q · filed 2020-10-29 | $65.93M derived: sum of 4 quarters · filed 2021-02-18 | |
| 2019-06-30 | $16.42M 10-Q · filed 2020-07-31 | $32.98M 10-Q · filed 2020-07-31 | $49.52M derived: sum of 3 quarters · filed 2021-02-18 | $66.42M derived: sum of 4 quarters · filed 2021-02-18 | |
| 2019-03-31 | $16.56M 10-Q · filed 2020-05-06 | $33.10M derived: sum of 2 quarters · filed 2021-02-18 | $50.00M derived: sum of 3 quarters · filed 2021-02-18 | $67.22M derived: sum of 4 quarters · filed 2021-02-18 | |
| 2018-12-31 | $16.54M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-18 | $33.44M derived: sum of 2 quarters · filed 2021-02-18 | $50.66M derived: sum of 3 quarters · filed 2021-02-18 | $67.93M 10-K · filed 2021-02-18 | |
| 2018-09-30 | $16.90M 10-Q · filed 2019-11-05 | $34.13M derived: sum of 2 quarters · filed 2019-11-05 | $51.40M 10-Q · filed 2019-11-05 | $68.98M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-06-30 | $17.23M 10-Q · filed 2019-08-07 | $34.50M 10-Q · filed 2019-08-07 | $52.08M derived: sum of 3 quarters · filed 2020-03-02 | $70.10M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-03-31 | $17.27M 10-Q · filed 2019-05-08 | $34.85M derived: sum of 2 quarters · filed 2020-03-02 | $52.87M derived: sum of 3 quarters · filed 2020-03-02 | $70.83M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2017-12-31 | $17.58M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $35.60M derived: sum of 2 quarters · filed 2020-03-02 | $53.56M derived: sum of 3 quarters · filed 2020-03-02 | $71.48M 10-K · filed 2020-03-02 | $84.68M 10-K · filed 2018-03-01 |
| 2017-09-30 | $18.02M 10-Q · filed 2018-11-09 | $35.98M derived: sum of 2 quarters · filed 2018-11-09 | $53.90M 10-Q · filed 2018-11-09 | $70.97M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-06-30 | $17.95M 10-Q · filed 2018-08-07 | $35.88M 10-Q · filed 2018-08-07 | $52.95M derived: sum of 3 quarters · filed 2019-03-01 | $71.07M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-03-31 | $17.93M 10-Q · filed 2018-05-08 | $35.00M derived: sum of 2 quarters · filed 2019-03-01 | $53.12M derived: sum of 3 quarters · filed 2019-03-01 | $68.89M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2016-12-31 | $17.07M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $35.19M derived: sum of 2 quarters · filed 2019-03-01 | $50.96M derived: sum of 3 quarters · filed 2019-03-01 | $64.41M 10-K · filed 2019-03-01 | |
| 2016-09-30 | $18.12M 10-Q · filed 2017-11-08 | $33.89M derived: sum of 2 quarters · filed 2017-11-08 | $47.34M 10-Q · filed 2017-11-08 | $61.30M derived: sum of 4 quarters · filed 2019-01-29 | |
| 2016-06-30 | $15.78M 10-Q · filed 2017-08-08 | $29.22M 10-Q · filed 2017-08-08 | $43.19M derived: sum of 3 quarters · filed 2019-01-29 | $51.30M derived: sum of 4 quarters · filed 2019-01-29 | |
| 2016-03-31 | $13.44M 10-Q · filed 2017-05-10 | $27.41M derived: sum of 2 quarters · filed 2019-01-29 | $35.52M derived: sum of 3 quarters · filed 2019-01-29 | $38.76M derived: sum of 4 quarters · filed 2019-01-29 | |
| 2015-12-31 | $13.97M derived: 8-K 12 month − 10-Q 9 month · filed 2019-01-29 | $22.08M derived: sum of 2 quarters · filed 2019-01-29 | $25.31M derived: sum of 3 quarters · filed 2019-01-29 | $27.98M 8-K · filed 2019-01-29 | |
| 2015-09-30 | $8.11M 10-Q · filed 2016-11-07 | $11.35M derived: sum of 2 quarters · filed 2016-11-07 | $14.01M 10-Q · filed 2016-11-07 | $16.63M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2015-06-30 | $3.24M 10-Q · filed 2016-08-08 | $5.90M 10-Q · filed 2016-08-08 | $8.52M derived: sum of 3 quarters · filed 2017-03-01 | $11.25M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2015-03-31 | $2.67M 10-Q · filed 2016-05-09 | $5.28M derived: sum of 2 quarters · filed 2017-03-01 | $8.02M derived: sum of 3 quarters · filed 2017-03-01 | $10.84M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2014-12-31 | $2.62M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $5.35M derived: sum of 2 quarters · filed 2017-03-01 | $8.18M derived: sum of 3 quarters · filed 2017-03-01 | $10.92M 10-K · filed 2017-03-01 | |
| 2014-09-30 | $2.73M 10-Q · filed 2015-11-09 | $5.56M derived: sum of 2 quarters · filed 2015-11-09 | $8.30M 10-Q · filed 2015-11-09 | $11.25M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-06-30 | $2.83M 10-Q · filed 2015-08-05 | $5.57M 10-Q · filed 2015-08-05 | $8.51M derived: sum of 3 quarters · filed 2016-02-29 | $11.30M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-03-31 | $2.74M 10-Q · filed 2015-05-11 | $5.68M derived: sum of 2 quarters · filed 2016-02-29 | $8.47M derived: sum of 3 quarters · filed 2016-02-29 | $11.16M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2013-12-31 | $2.94M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $5.73M derived: sum of 2 quarters · filed 2016-02-29 | $8.42M derived: sum of 3 quarters · filed 2016-02-29 | $11.13M 10-K · filed 2016-02-29 | |
| 2013-09-30 | $2.79M 10-Q · filed 2014-11-07 | $5.48M derived: sum of 2 quarters · filed 2014-11-07 | $8.19M 10-Q · filed 2014-11-07 | $10.25M derived: sum of 4 quarters · filed 2015-02-27 | |
| 2013-06-30 | $2.69M 10-Q · filed 2014-08-11 | $5.40M 10-Q · filed 2014-08-11 | $7.46M derived: sum of 3 quarters · filed 2015-02-27 | $9.64M derived: sum of 4 quarters · filed 2015-02-27 | |
| 2013-03-31 | $2.71M 10-Q · filed 2014-05-09 | $4.77M derived: sum of 2 quarters · filed 2015-02-27 | $6.95M derived: sum of 3 quarters · filed 2015-02-27 | ||
| 2012-12-31 | $2.06M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $4.24M derived: sum of 2 quarters · filed 2015-02-27 | $8.34M 10-K · filed 2015-02-27 | $8.30M 10-K · filed 2013-03-18 | |
| 2012-09-30 | $2.18M 10-Q · filed 2013-11-12 | $6.28M 10-Q · filed 2013-11-12 | |||
| 2011-12-31 | $3.40M 10-K · filed 2014-03-03 | $3.40M 10-K · filed 2013-03-18 | |||
| 2010-12-31 | $2.10M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |